Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prokidney (PROK) Operating Expenses (2022 - 2025)

Prokidney (PROK) has disclosed Operating Expenses for 4 consecutive years, with $38.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses fell 20.86% to $38.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $172.0 million, a 10.0% increase, with the full-year FY2024 number at $183.8 million, up 21.27% from a year prior.
  • Operating Expenses was $38.8 million for Q3 2025 at Prokidney, down from $39.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $66.5 million in Q1 2022 to a low of $20.7 million in Q2 2022.
  • A 4-year average of $40.6 million and a median of $40.1 million in 2024 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: tumbled 38.5% in 2023, then soared 113.33% in 2024.
  • Prokidney's Operating Expenses stood at $30.2 million in 2022, then fell by 19.93% to $24.2 million in 2023, then surged by 113.33% to $51.6 million in 2024, then decreased by 24.96% to $38.8 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Operating Expenses are $38.8 million (Q3 2025), $39.9 million (Q2 2025), and $41.6 million (Q1 2025).